Loading…
Chinese maker of pharmaceutical packaging materials, such as rubber stoppers, for injectable-drug packaging.
Chinese maker of pharmaceutical packaging materials, such as rubber stoppers, for injectable-drug packaging.
Moat: narrow (customer qualification, regulatory licence). Pharma-grade packaging materials require drug-regulatory qualification, creating switching costs.
Headquarters: Jiangsu, China · Employees: 945
Size Jiangsu Hualan New Pharmaceutical Material (301093.SZ) is a China Materials company (Containers/Packaging) with a market value of $1.53B, the 1605th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥47.99 on 6 Nov 2026.
Performance Over six months the shares fell 26.9%, against -6.2% for the median peer and -16.4% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.
Growth Revenue grew 5.5% over the last twelve months (peer median +0.6%); the operating margin is 4.6% (peer median 6.5%).
Valuation It trades at 77.4× forward earnings against a peer median of 15.7× (2nd most expensive of 19).
Price implies For today's price to make sense, revenue must grow about 51% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +44 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 5.6 points below its cost of capital (10.9% WACC).
Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥638M | CN¥618M | CN¥584M | CN¥620M | CN¥581M |
| Revenue growth | — | +6% | -6% | +7% | — |
| Gross profit | CN¥302M | CN¥209M | CN¥195M | CN¥232M | CN¥233M |
| EBITDA | n/a | CN¥131M | CN¥108M | CN¥134M | CN¥120M |
| Net income | CN¥39.1M | CN¥60.2M | CN¥49.6M | CN¥118M | CN¥93.8M |
| Free cash flow | CN¥66.0M | CN¥8.01M | CN¥31.9M | -CN¥36.7M | -CN¥68.8M |
| Capital expenditure | CN¥98.8M | CN¥133M | CN¥135M | CN¥297M | CN¥174M |
| Total debt | CN¥228M | CN¥176M | CN¥59.9M | CN¥61.0M | CN¥49.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Jiangsu Hualan New Pharmaceutical Material 301093.SZ | $1.53B | -27% | +6% | 5% | 77.4× | 50.9% |
| West Pharmaceutical Services WST | $27.9B | +23% | +13% | 23% | 39.8× | 25.2% |
| Shandong Pharmaceutical Glass 600529.SS | $1.85B | 0% | -9% | 18% | 16.5× | -2.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301093.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -20.5% | +0.6% | 2nd lowest of 21 |
| 6-month return | -26.9% | -6.2% | 4th lowest of 21 |
| Distance from 52-week high | -56.5% | -23.0% | 3rd lowest of 21 |
| Revenue growth (TTM) | +5.5% | +0.6% | 7th highest of 21 |
| Operating margin | 4.6% | 6.5% | 6th lowest of 21 |
| Forward P/E | 77.4× | 15.7× | 2nd most expensive of 19 |
| Growth the price implies (Req g, 7 yrs) | 50.9% | -1.9% | 2nd most demanding of 12 |
| Growth delivered (Del g) | +6.7% | +5.9% | 5th highest of 12 |
| Hurdle (Req g minus delivered) | +44.2 pp | -5.0 pp | 2nd most demanding of 12 |
| ROIC minus cost of capital | -5.6 pp | +0.8 pp | 5th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jiangsu Hualan New Pharmaceutical Material 301093.SZ | China | $1.53B | -27% | +6% | 5% | 77.4× | 50.9% | +6.7% |
| Shanghai Zijiang Enterprise 600210.SS | China | $1.54B | -3% | -18% | 10% | 11.3× | n/a | n/a |
| Shanghai Shunho New Materials Technology 002565.SZ | China | $1.51B | -50% | -15% | -3% | n/a | n/a | n/a |
| Jiamei Food Packaging (Chuzhou) 002969.SZ | China | $1.55B | -56% | -10% | 6% | 86.4× | 22.4% | +7.3% |
| ORG Technology 002701.SZ | China | $1.65B | -22% | +24% | 5% | 9.6× | -5.2% | +15.8% |
| TriMas TRS | United States | $1.37B | -10% | -33% | 5% | 19.1× | n/a | n/a |
| Orora ORA.AX | Australia | $1.34B | +17% | +6% | 11% | 15.8× | 2.5% | -8.9% |
| Shandong Pharmaceutical Glass 600529.SS | China | $1.85B | 0% | -9% | 18% | 16.5× | -2.4% | +5.5% |
| Shenzhen Leaguer 002243.SZ | China | $1.27B | -18% | +5% | -3% | 19.9× | 44.6% | +1.6% |
| Winpak WPK.TO | Canada | $1.91B | +12% | +3% | 15% | 12.5× | -10.9% | +6.6% |
| Shenzhen Changhong Technology 300151.SZ | China | $1.23B | -12% | -1% | 6% | 59.9× | n/a | n/a |
| Gerresheimer GXI.DE | Germany | $1.21B | +24% | +9% | -4% | 18.0× | 55.8% | +10.3% |
| Fuji Seal International 7864.T | Japan | $1.18B | +38% | +4% | 9% | 10.8× | -9.5% | +5.9% |
| Cascades CAS.TO | Canada | $1.15B | +49% | +1% | 5% | 9.2× | -1.9% | +3.1% |
| Jia Yao 1626.HK | Hong Kong | $2.05B | +175% | +161% | 6% | n/a | n/a | n/a |
| Suzhou Hycan 002787.SZ | China | $1.09B | -10% | 0% | 7% | 36.4× | n/a | n/a |
| Taiwan Hon Chuan Enterprise 9939.TW | Taiwan | $1.07B | +7% | 0% | 15% | 10.2× | n/a | n/a |
| Huangshan Novel 002014.SZ | China | $1.02B | +5% | +9% | 12% | 15.7× | n/a | n/a |
| Elopak ELO.OL | Norway | $1.01B | -11% | 0% | 9% | 11.8× | -8.3% | +7.7% |
| Zhejiang Great Shengda Packing 603687.SS | China | $995M | -30% | +1% | 3% | 32.6× | n/a | n/a |
| Zhejiang Zhongxin Environmental Protection Technology 603091.SS | China | $991M | -20% | +31% | 22% | 14.5× | 7.8% | +4.4% |